JPWO2023164464A5 - - Google Patents

Info

Publication number
JPWO2023164464A5
JPWO2023164464A5 JP2024549489A JP2024549489A JPWO2023164464A5 JP WO2023164464 A5 JPWO2023164464 A5 JP WO2023164464A5 JP 2024549489 A JP2024549489 A JP 2024549489A JP 2024549489 A JP2024549489 A JP 2024549489A JP WO2023164464 A5 JPWO2023164464 A5 JP WO2023164464A5
Authority
JP
Japan
Prior art keywords
alkyl
optionally substituted
halogen
conjugate
halogens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024549489A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025508785A5 (https=
JP2025508785A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/062996 external-priority patent/WO2023164464A1/en
Publication of JP2025508785A publication Critical patent/JP2025508785A/ja
Publication of JPWO2023164464A5 publication Critical patent/JPWO2023164464A5/ja
Publication of JP2025508785A5 publication Critical patent/JP2025508785A5/ja
Pending legal-status Critical Current

Links

JP2024549489A 2022-02-22 2023-02-22 5’修飾炭素環式リボヌクレオチド誘導体及び使用方法 Pending JP2025508785A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263312554P 2022-02-22 2022-02-22
US63/312,554 2022-02-22
PCT/US2023/062996 WO2023164464A1 (en) 2022-02-22 2023-02-22 5'-modified carbocyclic ribonucleotide derivatives and methods of use

Publications (3)

Publication Number Publication Date
JP2025508785A JP2025508785A (ja) 2025-04-10
JPWO2023164464A5 true JPWO2023164464A5 (https=) 2026-03-03
JP2025508785A5 JP2025508785A5 (https=) 2026-03-03

Family

ID=85778954

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024549489A Pending JP2025508785A (ja) 2022-02-22 2023-02-22 5’修飾炭素環式リボヌクレオチド誘導体及び使用方法

Country Status (9)

Country Link
US (1) US20230346819A1 (https=)
EP (1) EP4482845A1 (https=)
JP (1) JP2025508785A (https=)
KR (1) KR20240169616A (https=)
CN (1) CN118922431A (https=)
AU (1) AU2023224208A1 (https=)
CA (1) CA3252536A1 (https=)
IL (1) IL314850A (https=)
WO (1) WO2023164464A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN121194983A (zh) * 2023-04-06 2025-12-23 上海舶望制药有限公司 5'-膦酸酯修饰的核苷类似物及其制备的寡核苷酸
WO2025191337A2 (en) * 2024-03-11 2025-09-18 Synerk Biotech Limited Oligonucleotide terminal phosphate derivatives and method of use
WO2026017140A2 (en) 2024-07-18 2026-01-22 Sanegene Bio Usa Inc. Small interfering rna targeting fxi and uses thereof
WO2026041067A2 (en) 2024-08-20 2026-02-26 Sanegene Bio Usa Inc. Small interfering rna targeting myostatin (mstn) and uses thereof
WO2026046411A1 (en) 2024-09-02 2026-03-05 Sanegene Bio Usa Inc. Small interfering rna targeting plasminogen (plg) and uses thereof
US12454693B1 (en) 2024-09-27 2025-10-28 Dexcel Pharma Technologies Ltd. Nucleic acids for inhibiting expression of transferrin receptor 2

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1154A (en) 1839-05-17 Spiral-bucket watek-wheel
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US5453566A (en) 1986-03-28 1995-09-26 Calgene, Inc. Antisense regulation of gene expression in plant/cells
US4987071A (en) 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
CA1340323C (en) 1988-09-20 1999-01-19 Arnold E. Hampel Rna catalyst for cleaving specific rna sequences
GB8822492D0 (en) 1988-09-24 1988-10-26 Considine J Apparatus for removing tumours from hollow organs of body
AU637800B2 (en) 1989-08-31 1993-06-10 City Of Hope Chimeric dna-rna catalytic sequences
US6365730B1 (en) 1990-06-19 2002-04-02 Gene Shears Pty. Limited DNA-Armed ribozymes and minizymes
US5789573A (en) 1990-08-14 1998-08-04 Isis Pharmaceuticals, Inc. Antisense inhibition of ICAM-1, E-selectin, and CMV IE1/IE2
JP3257675B2 (ja) 1990-10-12 2002-02-18 マックス−プランク−ゲゼルシャフト ツール フェルデルング デル ビッセンシャフテン エー.ファウ. 修飾リボザイム
DE4216134A1 (de) 1991-06-20 1992-12-24 Europ Lab Molekularbiolog Synthetische katalytische oligonukleotidstrukturen
US5652094A (en) 1992-01-31 1997-07-29 University Of Montreal Nucleozymes
EP0642589A4 (en) 1992-05-11 1997-05-21 Ribozyme Pharm Inc METHOD AND REAGENT TO INHIBIT VIRAL REPLICATION.
WO1994002595A1 (en) 1992-07-17 1994-02-03 Ribozyme Pharmaceuticals, Inc. Method and reagent for treatment of animal diseases
IL108367A0 (en) 1993-01-27 1994-04-12 Hektoen Inst For Medical Resea Antisense polynzcleotide inhibition of human growth factor-sensitive cancer cells
US5591317A (en) 1994-02-16 1997-01-07 Pitts, Jr.; M. Michael Electrostatic device for water treatment
US5631359A (en) 1994-10-11 1997-05-20 Ribozyme Pharmaceuticals, Inc. Hairpin ribozymes
AU3889595A (en) 1994-10-05 1996-05-02 Amgen, Inc. Method for inhibiting smooth muscle cell proliferation and oligonucleotides for use therein
US5783683A (en) 1995-01-10 1998-07-21 Genta Inc. Antisense oligonucleotides which reduce expression of the FGFRI gene
US5747470A (en) 1995-06-07 1998-05-05 Gen-Probe Incorporated Method for inhibiting cellular proliferation using antisense oligonucleotides to gp130 mRNA
US5763263A (en) 1995-11-27 1998-06-09 Dehlinger; Peter J. Method and apparatus for producing position addressable combinatorial libraries
US5739119A (en) 1996-11-15 1998-04-14 Galli; Rachel L. Antisense oligonucleotides specific for the muscarinic type 2 acetylcholine receptor MRNA
WO2004080406A2 (en) 2003-03-07 2004-09-23 Alnylam Pharmaceuticals Therapeutic compositions
DK1620544T3 (en) 2003-04-17 2019-01-14 Alnylam Pharmaceuticals Inc MODIFIED iRNA AGENTS
WO2007021896A2 (en) 2005-08-10 2007-02-22 Alnylam Pharmaceuticals, Inc. Chemically modified oligonucleotides for use in modulating micro rna and uses thereof
US20070213292A1 (en) 2005-08-10 2007-09-13 The Rockefeller University Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof
WO2009082607A2 (en) 2007-12-04 2009-07-02 Alnylam Pharmaceuticals, Inc. Targeting lipids
WO2011139699A2 (en) * 2010-04-28 2011-11-10 Isis Pharmaceuticals, Inc. 5' modified nucleosides and oligomeric compounds prepared therefrom
KR101869570B1 (ko) * 2010-04-28 2018-06-20 아이오니스 파마수티컬즈, 인코포레이티드 변형된 뉴클레오사이드 및 그로부터 제조된 올리고머 화합물
ES2605990T3 (es) 2010-12-29 2017-03-17 F. Hoffmann-La Roche Ag Conjugados de molécula pequeña para la administración intracelular de ácidos nucleicos
US8577565B2 (en) 2011-12-16 2013-11-05 GM Global Technology Operations LLC Limiting branch pressure to a solenoid valve in a fluid circuit
US9896688B2 (en) * 2013-02-22 2018-02-20 Sirna Therapeutics, Inc. Short interfering nucleic acid (siNA) molecules containing a 2′ internucleoside linkage
JP6702862B2 (ja) 2013-07-11 2020-06-03 アルニラム ファーマスーティカルズ インコーポレイテッドAlnylam Pharmaceuticals, Inc. オリゴヌクレオチド−リガンドコンジュゲートおよびそれらの調製方法
JP7105065B2 (ja) 2014-12-15 2022-07-22 ダイセルナ ファーマシューティカルズ, インコーポレイテッド リガンド修飾二本鎖核酸
WO2017214112A1 (en) 2016-06-06 2017-12-14 Arrowhead Pharmaceuticals, Inc. 5'-cyclo-phosphonate modified nucleotides
JP7249080B2 (ja) 2016-08-23 2023-03-30 ディセルナ ファーマシューティカルズ インコーポレイテッド 可逆的に修飾されたオリゴヌクレオチドを含む組成物及びその使用
KR102350647B1 (ko) 2016-09-02 2022-01-14 다이서나 파마수이티컬, 인크. 4'-포스페이트 유사체 및 이를 포함하는 올리고뉴클레오타이드

Similar Documents

Publication Publication Date Title
JP7740719B2 (ja) ホスホルアミダイト化学を使用する骨格修飾モルホリノオリゴヌクレオチド及びキメラの合成
JP7008056B2 (ja) 修飾されたサブユニット間結合および/または末端基を有するオリゴヌクレオチドアナログ
JP2025041652A5 (https=)
CN106188192B (zh) 含d-氨基酸酯的核苷氨基磷酸/膦酸酯衍生物及其医药用途
CN1964967B (zh) 路易斯酸介导的环状酯的合成
CN104640444B (zh) 双肝脏靶向氨基磷酸酯和氨基膦酸酯前药
JP2020111607A (ja) ペプチドオリゴヌクレオチドコンジュゲート
CN103980318A (zh) 含有取代苄基的新型核苷磷酸酯前药及其制备方法和用途
JP2023541427A (ja) 骨格筋送達プラットフォーム及び使用方法
JP2021090458A5 (https=)
JP6542662B2 (ja) オリゴヌクレオチドアナログのボロン酸結合体
JP2015063538A (ja) ヌクレオシドホスホナートが投与された被験者における腎毒性を減少させる方法
JP2010510301A (ja) 化合物
JP2010275254A (ja) 疎水性基結合ヌクレオシド、疎水性基結合ヌクレオシド溶液、及び疎水性基結合オリゴヌクレオチド合成方法
JP2018538302A5 (https=)
TW202227135A (zh) 用於遞送治療劑之脂質結合物
CA2436665C (en) Nucleic acid derivatives
JPWO2023164464A5 (https=)
PL192832B1 (pl) Pochodna 5'-dezoksy-cytydyny, sposób jej wytwarzania, jej zastosowanie, kompozycja farmaceutyczna ją zawierająca oraz zestaw
JPWO2023014938A5 (https=)
JP2018518167A5 (https=)
JPWO2023049258A5 (https=)
JPWO2019231824A5 (https=)
JPWO2023178230A5 (https=)
US6900307B1 (en) 2-aminopurine derivatives